314 related articles for article (PubMed ID: 22791398)
1. Cardiovascular disease and rheumatoid arthritis: an update.
Charles-Schoeman C
Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
John H; Kitas G
Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
[TBL] [Abstract][Full Text] [Related]
4. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.
Castañeda S; González-Juanatey C; González-Gay MA
Clin Rev Allergy Immunol; 2019 Jun; 56(3):278-292. PubMed ID: 28852999
[TBL] [Abstract][Full Text] [Related]
5. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Danninger K; Hoppe UC; Pieringer H
Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.
McCarey D; Sturrock RD
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S124-6. PubMed ID: 19822058
[TBL] [Abstract][Full Text] [Related]
7. Spondyloarthropathies: an independent cardiovascular risk factor?
Mathieu S; Motreff P; Soubrier M
Joint Bone Spine; 2010 Dec; 77(6):542-5. PubMed ID: 20646947
[TBL] [Abstract][Full Text] [Related]
8. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.
Amezaga Urruela M; Suarez-Almazor ME
Curr Rheumatol Rep; 2012 Oct; 14(5):428-37. PubMed ID: 22802154
[TBL] [Abstract][Full Text] [Related]
9. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
Shan J; Zhang J
Joint Bone Spine; 2019 Mar; 86(2):173-183. PubMed ID: 29635017
[TBL] [Abstract][Full Text] [Related]
10. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Agca R; Heslinga SC; Rollefstad S; Heslinga M; McInnes IB; Peters MJ; Kvien TK; Dougados M; Radner H; Atzeni F; Primdahl J; Södergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen TR; Jacobsson L; de Vlam K; Gonzalez-Gay MA; Semb AG; Kitas GD; Smulders YM; Szekanecz Z; Sattar N; Symmons DP; Nurmohamed MT
Ann Rheum Dis; 2017 Jan; 76(1):17-28. PubMed ID: 27697765
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study.
Rotar Z; Svetina P; Tomsic M; Hočevar A; Prapotnik S
BMJ Open; 2020 Feb; 10(2):e034356. PubMed ID: 32029494
[TBL] [Abstract][Full Text] [Related]
12. Unmet needs in the management of cardiovascular risk in inflammatory joint diseases.
Castañeda S; Vicente-Rabaneda EF; García-Castañeda N; Prieto-Peña D; Dessein PH; González-Gay MA
Expert Rev Clin Immunol; 2020 Jan; 16(1):23-36. PubMed ID: 31779487
[No Abstract] [Full Text] [Related]
13. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
Fragoulis GE; Panayotidis I; Nikiphorou E
Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
[TBL] [Abstract][Full Text] [Related]
15. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
[TBL] [Abstract][Full Text] [Related]
16. [Rheumatoid arthritis: a cardiovascular disease?].
Daïen CI; Fesler P
Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.
Burmester GR; Cohen SB; Winthrop KL; Nash P; Irvine AD; Deodhar A; Mysler E; Tanaka Y; Liu J; Lacerda AP; Palac H; Shaw T; Mease PJ; Guttman-Yassky E
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36754548
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.
Ferguson LD; Siebert S; McInnes IB; Sattar N
Nat Rev Rheumatol; 2019 Aug; 15(8):461-474. PubMed ID: 31292564
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng H; Lam SH; So H; Tam LS
Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
